We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock

Delisted

YTEN was delisted on the 15th of May, 2024.

13 hedge funds and large institutions have $1.58M invested in Yield10 Bioscience, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

8% more funds holding

Funds holding: 1213 (+1)

6% more capital invested

Capital invested by funds: $1.5M → $1.58M (+$85K)

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

YTEN Hedge Fund Activity: Q3 2018 in Review

13 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q3 2018, worth a combined $1.58M — up 5.7% from $1.5M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new YTEN positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $40.8K. The largest seller was Virtu Financial, exiting entirely with an estimated $36K sold.

  • 13 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q3 2018, up from 12 in Q2 2018.
  • Funds reported $1.58M of Yield10 Bioscience, Inc. Common Stock stock for Q3 2018, up 5.7% quarter-over-quarter.
  • 4 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q3 2018 and 3 closed out, a net change of +1 holder.
  • The largest Yield10 Bioscience, Inc. Common Stock buyer in Q3 2018 was Citadel Advisors, an estimated $40.8K added.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q3 2018 was Virtu Financial, an estimated $36K sold.

Based on aggregated 13F filings for Q3 2018.